Afya Limited Announces Second-Quarter and First-Half 2025 Financial Results
BELO HORIZONTE, Brazil--(BUSINESS WIRE)--Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, re...
What key risks or uncertainties did management highlight in the MD&A that traders should monitor?
Is there any update on dividend policy or share repurchase programs that could affect shareholder returns?
How does the company's liquidity position look, including cash on hand and debt levels, following the results?
14 days ago